Cargando…

Biogenesis of HLA Ligand Presentation in Immune Cells Upon Activation Reveals Changes in Peptide Length Preference

Induction of an effective tumor immunity is a complex process that includes the appropriate presentation of the tumor antigens, activation of specific T cells, and the elimination of malignant cells. Potent and efficient T cell activation is dependent on multiple factors, such as timely expression o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marino, Fabio, Semilietof, Aikaterini, Michaux, Justine, Pak, Hui-Song, Coukos, George, Müller, Markus, Bassani-Sternberg, Michal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485268/ https://www.ncbi.nlm.nih.gov/pubmed/32983136 http://dx.doi.org/10.3389/fimmu.2020.01981

Ejemplares similares

Sensitive Immunopeptidomics by Leveraging Available Large-Scale Multi-HLA Spectral Libraries, Data-Independent Acquisition, and MS/MS Prediction
por: Pak, HuiSong, et al.
Publicado: (2021)

Deciphering the landscape of phosphorylated HLA-II ligands
por: Solleder, Marthe, et al.
Publicado: (2022)

Analysis of Secondary Structure Biases in Naturally Presented HLA-I Ligands
por: Perez, Marta A. S., et al.
Publicado: (2019)

High-throughput and Sensitive Immunopeptidomics Platform Reveals Profound Interferonγ-Mediated Remodeling of the Human Leukocyte Antigen (HLA) Ligandome
por: Chong, Chloe, et al.
Publicado: (2018)

Estimating the Contribution of Proteasomal Spliced Peptides to the HLA-I Ligandome*
por: Mylonas, Roman, et al.
Publicado: (2018)

Deciphering HLA-I motifs across HLA peptidomes improves neo-antigen predictions and identifies allostery regulating HLA specificity
por: Bassani-Sternberg, Michal, et al.
Publicado: (2017)

CIITA-Transduced Glioblastoma Cells Uncover a Rich Repertoire of Clinically Relevant Tumor-Associated HLA-II Antigens
por: Forlani, Greta, et al.
Publicado: (2021)

‘Hotspots’ of Antigen Presentation Revealed by Human Leukocyte Antigen Ligandomics for Neoantigen Prioritization
por: Müller, Markus, et al.
Publicado: (2017)

Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment
por: Newey, Alice, et al.
Publicado: (2019)

A microfluidics-enabled automated workflow of sample preparation for MS-based immunopeptidomics
por: Li, Xiaokang, et al.
Publicado: (2023)

Mass spectrometry–driven exploration reveals nuances of neoepitope-driven tumor rejection
por: Ebrahimi-Nik, Hakimeh, et al.
Publicado: (2019)

Bedside formulation of a personalized multi-neoantigen vaccine against mammary carcinoma
por: Mohsen, Mona O, et al.
Publicado: (2022)

The immunopeptidome landscape associated with T cell infiltration, inflammation and immune editing in lung cancer
por: Kraemer, Anne I., et al.
Publicado: (2023)

P32. High resolution mass spectrometry reveals the depth and diversity of HLA-I peptidomes
por: Bassani-Sternberg, M, et al.
Publicado: (2014)

A Phase Ib Study of the Combination of Personalized Autologous Dendritic Cell Vaccine, Aspirin, and Standard of Care Adjuvant Chemotherapy Followed by Nivolumab for Resected Pancreatic Adenocarcinoma—A Proof of Antigen Discovery Feasibility in Three Patients
por: Bassani-Sternberg, Michal, et al.
Publicado: (2019)

Reversion analysis reveals the in vivo immunogenicity of a poorly MHC I-binding cancer neoepitope
por: Ebrahimi-Nik, Hakimeh, et al.
Publicado: (2021)

Integrated proteogenomic deep sequencing and analytics accurately identify non-canonical peptides in tumor immunopeptidomes
por: Chong, Chloe, et al.
Publicado: (2020)

Predicting Antigen Presentation—What Could We Learn From a Million Peptides?
por: Gfeller, David, et al.
Publicado: (2018)

HLA-F*01:01 presents peptides with N-terminal flexibility and a preferred length of 16 residues
por: Hò, Gia-Gia T., et al.
Publicado: (2019)

Rapid tumor vaccine using Toll-like receptor-activated ovarian cancer ascites monocytes
por: Adams, Sarah F, et al.
Publicado: (2020)

Current perspectives on mass spectrometry-based immunopeptidomics: the computational angle to tumor antigen discovery
por: Zhang, Bing, et al.
Publicado: (2023)

Editorial: Immunopeptidomic Approaches for the Identification of Tumor (neo)Antigens
por: Lill, Jennie R., et al.
Publicado: (2022)

Deciphering the Mechanisms of Improved Immunogenicity of Hypochlorous Acid-Treated Antigens in Anti-Cancer Dendritic Cell-Based Vaccines
por: Graciotti, Michele, et al.
Publicado: (2020)

HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy
por: Marcu, Ana, et al.
Publicado: (2021)

Forward Vaccinology: CTL Targeting Based upon Physical Detection of HLA-Bound Peptides
por: Reinherz, Ellis L., et al.
Publicado: (2014)

HLA-G peptide preferences change in transformed cells: impact on the binding motif
por: Celik, Alexander A., et al.
Publicado: (2018)

Insights into the Observed trans-Bond Length Variations upon NO Binding to Ferric and Ferrous Porphyrins with Neutral Axial Ligands
por: Khade, Rahul L., et al.
Publicado: (2021)

Human histocompatibility leukocyte antigen (HLA)-DM edits peptides presented by HLA-DR according to their ligand binding motifs
Publicado: (1996)

Structures of liganded glycosylphosphatidylinositol transamidase illuminate GPI-AP biogenesis
por: Xu, Yidan, et al.
Publicado: (2023)

Low Avidity T Cells Do Not Hinder High Avidity T Cell Responses Against Melanoma
por: Ioannidou, Kalliopi, et al.
Publicado: (2019)

Crystal structures of N-myristoylated lipopeptide-bound HLA class I complexes indicate reorganization of B-pocket architecture upon ligand binding
por: Asa, Minori, et al.
Publicado: (2022)

Toxoplasma gondii peptide ligands open the gate of the HLA class I binding groove
por: McMurtrey, Curtis, et al.
Publicado: (2016)

Unbiased Characterization of Peptide-HLA Class II Interactions Based on Large-Scale Peptide Microarrays; Assessment of the Impact on HLA Class II Ligand and Epitope Prediction
por: Wendorff, Mareike, et al.
Publicado: (2020)

Structure of human Dispatched-1 provides insights into Hedgehog ligand biogenesis
por: Chen, Hongwen, et al.
Publicado: (2020)

TIE-2-expressing monocytes are lymphangiogenic and associate specifically with lymphatics of human breast cancer
por: Bron, Sylvian, et al.
Publicado: (2015)

Hydrogen Bonding Penalty upon Ligand Binding
por: Zhao, Hongtao, et al.
Publicado: (2011)

Tumour-reactive T cell subsets in the microenvironment of ovarian cancer
por: Westergaard, Marie Christine Wulff, et al.
Publicado: (2019)

Correction: Tumour-reactive T cell subsets in the microenvironment of ovarian cancer
por: Westergaard, Marie Christine Wulff, et al.
Publicado: (2019)

A Phase I/II trial comparing autologous dendritic cell vaccine pulsed either with personalized peptides (PEP-DC) or with tumor lysate (OC-DC) in patients with advanced high-grade ovarian serous carcinoma
por: Sarivalasis, Apostolos, et al.
Publicado: (2019)

All-Atom Simulations Reveal the Intricacies of Signal Transduction upon Binding of the HLA-E Ligand to the Transmembrane Inhibitory CD94/NKG2A Receptor
por: Ljubič, Martin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_asbt3cc88q2kfo6eje8ms5r9ik